ZyVersa Therapeutics, Inc.

NASDAQ (USD): ZyVersa Therapeutics, Inc. (ZVSA)

Last Price

2.48

Today's Change

+0.65 (35.51%)

Day's Change

2.35 - 3.37

Trading Volume

57,885,262

Overview

Market Cap

2 Million

Shares Outstanding

1 Million

Avg Volume

148,854

Avg Price (50 Days)

2.35

Avg Price (200 Days)

4.77

PE Ratio

0.00

EPS

1163.36

Earnings Announcement

12-Nov-2024

Previous Close

1.83

Open

2.66

Day's Range

2.3501 - 3.37

Year Range

1.82 - 42.35

Trading Volume

57,890,187

Price Change Highlight

1 Day Change

35.25%

5 Day Change

23.75%

1 Month Change

10.49%

3 Month Change

-23.85%

6 Month Change

-54.59%

Ytd Change

-71.88%

1 Year Change

-91.72%

3 Year Change

-99.93%

5 Year Change

-99.93%

10 Year Change

-99.93%

Max Change

-99.93%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment